Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL) News

Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL): $11.59

0.43 (-3.58%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add AVDL to Watchlist
Sign Up

Filter AVDL News Items

AVDL News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest AVDL News From Around the Web

Below are the latest news stories about AVADEL PHARMACEUTICALS PLC that investors may wish to consider to help them evaluate AVDL as an investment opportunity.

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript November 8, 2023 Avadel Pharmaceuticals plc misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.35. Operator: Greetings, and welcome to the Avadel Pharmaceuticals Third Quarter 2023 Earnings Call. [Operator Instructions]. It is now my pleasure to introduce Austin Murtagh with Stern Investor Relations. […]

Yahoo | November 10, 2023

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results

-- $7.0 million in third quarter LUMRYZ™ net revenue from U.S. commercial launch -- -- Generated robust demand for LUMRYZ with greater than 1,000 patients enrolled in RYZUPTM and more than 400 patients initiating therapy as of September 30 -- -- LUMRYZ to be added to preferred position for CVS commercial formularies effective January 1, 2024 -- -- Submitted sNDA for LUMRYZ in pediatric narcolepsy population on November 7th -- -- Management to host a conference call today at 8:30 a.m. ET -- DUBLI

Yahoo | November 8, 2023

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

DUBLIN, Ireland, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference: Fireside chat on Tuesday, November 14 at 5:00 p.m. GMT / 12:00 p.m. ET.Piper Sandler 35th Annual Healthcare Conference: Fireside chat on Wednesday, November 29 at 11:30 a.m. ET

Yahoo | November 7, 2023

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 8

DUBLIN, Ireland, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, November 8, 2023, to provide a corporate update and discuss the Company's financial results for the third quarter ended September 30, 2023. A live audio webcast of the call be accessed by visiting the investor relations secti

Yahoo | October 30, 2023

Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023

– 17 abstracts accepted, including new and encore data emphasizing clinical benefit and patient preference for a once-at-bedtime narcolepsy treatment option – – Company to host symposium on October 24 with leading KOLs discussing evolution of the narcolepsy treatment landscape – DUBLIN, Ireland, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced new and encore data supporting the clinical pr

Yahoo | October 20, 2023

Avadel Pharmaceuticals to Present at the Jefferies Biotech CNS/Neuro Summit

DUBLIN, Ireland, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Jefferies Biotech CNS/Neuro Summit on Thursday, October 12 at 9:00 a.m. ET. A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days

Yahoo | October 5, 2023

Avadel Pharmaceuticals PLC (AVDL): Is It Really Priced Right? An In-depth Exploration

Unraveling the True Worth of Avadel Pharmaceuticals PLC Amidst Market Fluctuations

Yahoo | September 26, 2023

Avadel Pharmaceuticals plc's (NASDAQ:AVDL) institutional investors lost 7.6% last week but have benefitted from longer-term gains

Key Insights Significantly high institutional ownership implies Avadel Pharmaceuticals' stock price is sensitive to...

Yahoo | September 23, 2023

12 Best High Risk High Reward Stocks To Buy Now

In this piece, we will take a look at the 12 best high risk high reward stocks to buy now. If you want to skip our background on investing, then head on over to 5 Best High Risk High Reward Stocks To Buy Now. Investing is a risky endeavor, as is anything that involves the […]

Yahoo | September 1, 2023

Geoffrey Glass Bought 13% More Shares In Avadel Pharmaceuticals

Potential Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) shareholders may wish to note that the Independent Non-Executive...

Yahoo | August 13, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!